Joel Abbott, MD
Rheumatology · Mountain Brk, ALNPI 1689659021
Payments from drug & device makers
Across 774 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Amgen$2K
- Novartis$2K
- E.r. Squibb & Sons, L.L.C.$1K
- Pfizer$987
- Johnson & Johnson$986
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 162 | $3,311 |
| Amgen(2 entities) | 112 | $1,941 |
| Novartis | 94 | $1,889 |
| E.r. Squibb & Sons, L.L.C. | 62 | $1,035 |
| Pfizer | 70 | $987 |
| Johnson & Johnson | 50 | $986 |
| UCB, Inc. | 53 | $835 |
| GSK | 44 | $747 |
| Mallinckrodt Hospital Products Inc. | 17 | $388 |
| Medexus Pharma, Inc. | 11 | $283 |
| Lilly USA, LLC | 16 | $283 |
| Genentech USA, Inc. | 14 | $218 |
| AstraZeneca(2 entities) | 6 | $200 |
| Radius Health, Inc. | 12 | $186 |
| Boehringer Ingelheim | 4 | $169 |
| ANI Pharmaceuticals, Inc. | 5 | $128 |
| Pacira Therapeutics, Inc. | 7 | $111 |
| Aurinia Pharma U.S., Inc. | 4 | $90 |
| Bristol Myers Squibb | 6 | $84 |
| Fresenius Kabi USA, LLC | 4 | $84 |
| Organon | 5 | $71 |
| Mallinckrodt Enterprises LLC | 3 | $64 |
| Astellas Pharma US Inc | 2 | $45 |
| Sobi, Inc | 2 | $32 |
| Tersera Therapeutics LLC | 1 | $29 |
| Sanofi | 1 | $27 |
| Almatica Pharma LLC | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Medtronic | 1 | $18 |
| Sandoz | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$14,354 in reported general payments places this provider in the 60th percentile of 90 rheumatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Mountain Brk
- Anthony TurkiewiczMountain Brk$2.5M
- Peter SawayMountain Brk$166K
- Maura KennedyMountain Brk$18K
- Laura ParksMountain Brk$16K
- William PaulMountain Brk$7K
- Jeffrey CurtisBirmingham$17.6M
- Kenneth SaagBirmingham$8.2M
- Vishala ChindaloreAnniston$3.5M
- Harry SchroederBirmingham$938K
- Jose Rubio MosqueraBirmingham$823K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.